Stockscreener 앱 받기
22.10
4.82%
-1.12
시간 외 거래:
22.42
0.32
+1.45%
Procept Biorobotics Corp 주식(PRCT)의 최신 뉴스
Why is Procept Biorobotics stock sliding today? By Investing.com - Investing.com South Africa
Why is Procept Biorobotics stock sliding today? - Investing.com
Procept BioRobotics shares slide after Leerink downgrade cites rising competitive risks - MSN
PROCEPT BioRobotics Shares Drop After Downgrade From Leerink Partners - marketscreener.com
This MarketAxess Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Thursday - Benzinga
Leerink downgrades Procept BioRobotics stock rating on competition - Investing.com UK
Leerink downgrades Procept BioRobotics stock rating on competition By Investing.com - Investing.com Canada
Procept BioRobotics EVP Nouri Alaleh sells $8,116 in stock By Investing.com - Investing.com Australia
Procept BioRobotics EVP Nouri Alaleh sells $8,116 in stock - Investing.com
PROCEPT BioRobotics (PRCT) director receives RSU and option grants as equity pay - Stock Titan
Director Amy Dodrill receives RSUs and options at PROCEPT (NASDAQ: PRCT) - Stock Titan
PROCEPT BioRobotics (PRCT) director Mary Garrett granted RSUs and options - Stock Titan
Director at PROCEPT BioRobotics (PRCT) receives new RSU and option awards - Stock Titan
Director at PROCEPT BioRobotics (PRCT) receives RSU and stock option grants - Stock Titan
Director Frederic Moll of PROCEPT BioRobotics (PRCT) granted RSUs and options - Stock Titan
PROCEPT BioRobotics (PRCT) director receives new RSU and stock option grants - Stock Titan
Director at PROCEPT (PRCT) granted RSUs and stock options - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) reports 2026 shareholder vote outcomes - Stock Titan
[Form 4] PROCEPT BioRobotics Corp Insider Trading Activity - Stock Titan
PRCT (NASDAQ: PRCT) files Form 144 for 285-share sale after vesting - Stock Titan
PRCT (NASDAQ) Rule 144 notice: Director activity, 357 vested shares reported - Stock Titan
PRCT (NASDAQ) insider sale notice — 358 vested shares to be sold - Stock Titan
PROCEPT BioRobotics (PRCT) Is Up 5.7% After New WATER IV Trials Expand Aquablation Testing Scope - simplywall.st
Procept secures FDA IDE for Aquablation and completes WATER IV study enrolment - MSN
Baird initiates Procept BioRobotics stock rating at Neutral - Investing.com
Procept BioRobotics appoints Daniel Puckett to board and audit committee - Investing.com
PROCEPT BioRobotics (PRCT) Is Down 9.2% After Aquablation WATER IV MilestonesWhat's Changed - Yahoo Finance
PROCEPT BioRobotics (PRCT) Is Down 6.0% After WATER IV Trial Milestones – Has The Bull Case Changed? - simplywall.st
Procept Biorobotics wins expanded FDA IDE for Aquablation, completes study enrollment - MassDevice
Siemens Healthineers, AiM team up; Procept completes study enrollment - Yahoo Finance
PROCEPT Biorobotics® Advances Prostate Cancer Program With WATER IV Study Enrollment Completion And Expanded IDE Approval - marketscreener.com
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval - markets.businessinsider.com
Procept BioRobotics completes enrollment in prostate cancer study By Investing.com - Investing.com South Africa
Procept BioRobotics completes enrollment in prostate cancer study - Investing.com
PROCEPT BioRobotics® Advances Prostate Cancer Program with - GlobeNewswire
A Look At PROCEPT BioRobotics (PRCT) Valuation After Its Better Than Expected Q1 Earnings And Analyst Updates - simplywall.st
Here’s What the Street Thinks About PROCEPT BioRobotics Corporation (PRCT) - Insider Monkey
PROCEPT BioRobotics Q1 2026 Earnings: Narrower-Than-Expected Loss Signals ProgressGross Profit Margin - The League of Women Voters of Texas
Lisanti Capital Growth LLC Buys Shares of 35,890 PROCEPT BioRobotics Corporation $PRCT - MarketBeat
DNB Asset Management AS Has $3.13 Million Stock Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
Will Stronger AUA Aquablation Guidelines Across Prostate Sizes Change PROCEPT BioRobotics' (PRCT) Narrative? - simplywall.st
AllianceBernstein (PRCT) discloses 147,327 shares; 0.3% stake reported - Stock Titan
PROCEPT BioRobotics Corporation (NASDAQ:PRCT) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
A Look At PROCEPT BioRobotics (PRCT) Valuation As AUA Guideline Update Expands Aquablation Opportunity - Sahm
1.21%
1.43%
자본화:
|
볼륨(24시간):